In a busy psychiatric emergency room, benztropine is one of the medications kept close at hand. A patient given a high-potency antipsychotic can develop a frightening neck spasm or eye-rolling reaction within hours, and a single dose of benztropine often resolves it within minutes. That history — fast, dramatic, lifesaving — is why this drug has been in continuous use since the 1950s.
Benztropine is an anticholinergic medication that treats antipsychotic-induced parkinsonism and acute dystonia by counteracting the dopamine-blocking effects of antipsychotics in the basal ganglia.
What benztropine treats
Benztropine, marketed as Cogentin, is approved by the FDA for the treatment of all forms of parkinsonism, including drug-induced parkinsonism, and for adjunctive control of acute dystonic reactions caused by antipsychotic medications. It is used in psychiatric practice almost exclusively for the second category.
Specifically, it helps with:
- Acute dystonia — sudden muscle contractions, often of the neck, eyes (oculogyric crisis), tongue, or jaw, usually within the first few days of starting an antipsychotic.
- Drug-induced parkinsonism — tremor, rigidity, slowed movement, mask-like face, shuffling gait.
- Some forms of akathisia, though it is less effective here than propranolol or mirtazapine.
It is generally not useful for tardive dyskinesia, and may even worsen it. For a primer on the broader category, see extrapyramidal symptoms.
How it works
Antipsychotics block dopamine D2 receptors. In the nigrostriatal pathway of the basal ganglia, that creates an imbalance between dopamine and acetylcholine, with relative excess cholinergic activity producing tremor, stiffness, and dystonia. Benztropine is a centrally acting anticholinergic — it blocks muscarinic receptors and rebalances the system. It also has mild antihistamine and dopamine reuptake-inhibiting properties.
Typical dosing
For acute dystonia, benztropine is often given as an injection (1 to 2 mg IM or IV), with relief usually within 15 to 30 minutes. For ongoing parkinsonism, the oral dose typically ranges from 0.5 to 6 mg per day in divided doses. Some people only need it for a few weeks while another medication change settles; others take it long term.
The cost of long-term use
Anticholinergic side effects are real, common, and often underestimated. The most familiar ones include:
- Dry mouth (see dry mouth on antipsychotics)
- Constipation — a real concern with clozapine combinations; see constipation on antipsychotics
- Blurred vision
- Urinary retention
- Tachycardia
The deeper concern, particularly with chronic use, is cognitive. Anticholinergic burden — the cumulative effect of all anticholinergic medications a person takes — has been linked in observational studies to memory problems, slowed processing, confusion in older adults, and possibly long-term dementia risk. The 2015 JAMA Internal Medicine study by Gray and colleagues, which looked at older adults, is one of the better-known examples.
Benztropine is on the Beers Criteria list of medications generally avoided in adults over 65 because of cognitive risk and fall risk. If you are caring for an older relative on benztropine, this is worth a focused conversation with their prescriber.
Hallucinations and delirium
At higher doses, or in people who are sensitive, anticholinergics can cause confusion, hallucinations (often visual or tactile), and delirium. Because the patients taking benztropine often also have a psychotic disorder, these effects can be missed or attributed to the underlying illness. A new symptom that started after benztropine was added or increased is worth flagging.
How long should you stay on it?
Many guidelines suggest reassessing after about three months. Movement side effects often settle as antipsychotic dose is adjusted or as the patient's body adapts. Tapering benztropine should be done gradually — abrupt withdrawal can produce a rebound of EPS or, occasionally, cholinergic rebound symptoms (nausea, sweating, vivid dreams).
Alternatives worth knowing about
- Trihexyphenidyl (Artane) — similar mechanism, sometimes preferred for younger adults.
- Amantadine — a non-anticholinergic option for parkinsonism.
- Reducing the antipsychotic dose, or switching to an antipsychotic with a lower EPS profile (quetiapine, olanzapine, clozapine, lurasidone at lower doses).
- For akathisia specifically, beta-blockers and mirtazapine usually work better than anticholinergics.
Questions to ask your prescriber
- What movement symptom are we treating, and how will we know it is working?
- Is the dose of my antipsychotic something we could lower instead?
- How long do you anticipate I will need benztropine?
- What other medications I am taking are anticholinergic?
- What should I look out for that might mean the dose is too high?
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.